Dr. Charles Fernandez Chong, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 936 Sharpe Hospital Rd, William Sharpe Jr. Hospital, Weston, WV 26452 Phone: 304-269-1210 Fax: 304-269-0502 |
Dr. David L Whetsell, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 24 Dogwood Ln, Weston, WV 26452 Phone: 304-257-3673 |
News Archive
Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing Toll-like receptor (TLR) and RNA therapeutics for patients with cancer and rare diseases, today announced that the company has commenced enrollment in a Phase 2 clinical trial of IMO-8400, an investigational TLR 7, 8 and 9 antagonist, in patients with dermatomyositis. Dermatomyositis is a rare and debilitating inflammatory muscle and skin disease associated with significant morbidity, decreased quality of life and an increased risk of premature death.
The Texas Senate on Wednesday voted 23-7 to approve a bill (S.B. 188) that would allow local state health agencies to run needle-exchange programs to help curb the spread of HIV and other bloodborne diseases among injection drug users, the Dallas Morning News reports. Texas is the only state that currently prohibits needle-exchange programs, according to the Morning News.
Trimel Pharmaceuticals Corporation (TSX: TRL) announced today top-line results of its Phase II clinical trial evaluating the efficacy and safety of Tefina™, a "use-as-required" testosterone nasal gel for the treatment of Female Orgasmic Disorder (FOD).
An extensive review of 25 randomized clinical trials found "little evidence" that invasive surgery was more effective than sham or placebo procedures in reducing chronic pain. The study was published in the journal Pain Medicine.
› Verified 3 days ago